Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
SANTA CLARA, CA & DUBAI, Feb 19, 2021 – (ACN Newswire) – Maculus Therapeutix, a preclinical-stage biopharmaceutical company that has developed a SINGLE injection platform to treat wet AMD (Age-related […]